bluebird bio (BLUE) AML Case is Unlikely Driven By Lentiglobin, Here's Why - Morgan Stanley

Go back to bluebird bio (BLUE) AML Case is Unlikely Driven By Lentiglobin, Here's Why - Morgan Stanley
BLUEBIRD BIO (NASDAQ: BLUE) Delayed: 30.34 +1.03 (3.51%)
Previous Close $29.31    52 Week High $95.28 
Open $29.34    52 Week Low $35.37 
Day High $30.74    P/E N/A 
Day Low $28.75    EPS $-1.81 
Volume 1,326,510